The Asian Scientist 100
Rong Wang
Institution
Nanyang Technological University, Singapore
Country
Singapore
Field
Sustainability
Wang was awarded the President’s Technology Award for her work in the field of membrane science and technology, in pursuit of sustainable energy-efficient liquid purification and desalination.
(Photo: Rong Wang)
AWARDS
- President's Science and Technology Award
Related articles
Igniting Innovation—Chew Ker Yee of Wangi Industrial
Collaborating with research institutions has helped precision optics company Wangi Industrial to deepen their competitive advance, says Vice President Chew Ker Yee.
Talk To A TechExpert Today
In the highly-regulated medical device sector, industry veterans on IPI’s TechExpert platform can help inventors and entrepreneurs avoid pitfalls and identify opportunities for growth.
Tapping Into The Global Innovation Marketplace
The Intellectual Property Intermediary Singapore is a gateway to global innovations, helping local and regional enterprises tap on technological solutions for future growth.
Engineering The Future Of Asia
By working at the intersections of the physical, digital and biological spheres, Asia's engineers are ushering in the Fourth Industrial Revolution.
Asian Scientist Magazine’s 2020 Roundup
Stories of scientific breakthroughs were bright spots in a year clouded by pandemic news. Here are Asian Scientist Magazine’s top 10 pieces of 2020.
The Future Of Food In Singapore
To achieve 30 percent local food production by 2030, Singapore’s most innovative minds are turning to genome editing, artificial intelligence and even microalgae-based proteins.
Making Hospital Medical Decisions Safer
A team of researchers and clinicians led by SMU Associate Professor Daniel Zheng is using advance data analytics to improve patient outcomes in hospitals.
Winners Of The Asian Scientist Writing Prize 2017 Announced
A total of 26 winners received their prizes at the Asian Scientist Writing Prize 2017 held at the Science Centre Singapore.
ASLAN And Bukwang Team Up To Develop Immune-Oncology Drugs
The joint venture has resulted in the independent company JAGUAHR Therapeutics, which will focus on developing aryl hydrocarbon receptor antagonists for cancer treatment.